HIV positive patient treated with ixekizumab
Abstract: Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
La Clinica terapeutica - 173(2022), 3 vom: 25. Mai, Seite 195-197 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bernardini, N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 27.05.2022 Date Revised 27.05.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.7417/CT.2022.2416 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341347450 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341347450 | ||
| 003 | DE-627 | ||
| 005 | 20231226011551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7417/CT.2022.2416 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM341347450 | ||
| 035 | |a (NLM)35612328 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bernardini, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV positive patient treated with ixekizumab |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.05.2022 | ||
| 500 | |a Date Revised 27.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Abstract: Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a Psoriasis | |
| 650 | 4 | |a psoriasis treatment | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a ixekizumab |2 NLM | |
| 650 | 7 | |a BTY153760O |2 NLM | |
| 700 | 1 | |a Skroza, N |e verfasserin |4 aut | |
| 700 | 1 | |a Tolino, E |e verfasserin |4 aut | |
| 700 | 1 | |a Marchesiello, A |e verfasserin |4 aut | |
| 700 | 1 | |a Mambrin, A |e verfasserin |4 aut | |
| 700 | 1 | |a Balduzzi, V |e verfasserin |4 aut | |
| 700 | 1 | |a Michelini, S |e verfasserin |4 aut | |
| 700 | 1 | |a Maddalena, P |e verfasserin |4 aut | |
| 700 | 1 | |a Volpe, S |e verfasserin |4 aut | |
| 700 | 1 | |a Proietti, I |e verfasserin |4 aut | |
| 700 | 1 | |a Potenza, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t La Clinica terapeutica |d 1958 |g 173(2022), 3 vom: 25. Mai, Seite 195-197 |w (DE-627)NLM000039187 |x 1972-6007 |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2022 |g number:3 |g day:25 |g month:05 |g pages:195-197 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7417/CT.2022.2416 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2022 |e 3 |b 25 |c 05 |h 195-197 | ||